fluorodeoxyglucose f18 has been researched along with Late Onset Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouckaert, F; De Winter, FL; Dupont, P; Emsell, L; Koole, M; Sunaert, S; Takamiya, A; Van den Stock, J; Van Laere, K; Vande Casteele, T; Vandenberghe, R; Vandenbulcke, M | 1 |
| Harada, K; Hasegawa, K; Otsuka, F | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Late Onset Diseases
| Article | Year |
|---|---|
Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloidogenic Proteins; Amyloidosis; Brain; Cognition; Depression; Depressive Disorder; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Late Onset Disorders; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Risk Factors | 2021 |
1 other study(ies) available for fluorodeoxyglucose f18 and Late Onset Diseases
| Article | Year |
|---|---|
Diffuse Vascular FDG Uptake in Late Onset Takayasu Arteritis.
Topics: Aged; Blood Sedimentation; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Late Onset Disorders; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Takayasu Arteritis; Tomography, X-Ray Computed; Treatment Outcome | 2019 |